INTRODUCTION {#sec1-1}
============

Obstructive sleep apnea (OSA) is a potentially serious sleep disorder. This is characteriszed by repeatedly stop and start breathing during sleep. There are several types of sleep apnea, but the most common is OSA. This type of apnea occurs when throat muscles intermittently relax and block the airway which leads to a noticeable sign of snoring.\[[@ref1]\]

Oral appliances or more commonly the mandibular repositioning appliances have been reported to provide reversible, simple, and cost-effective treatment for patients with primary snoring in mild to moderate OSA.\[[@ref2]\] These appliances cover all the teeth and they hold the mandible forward to relieve the obstruction. They can be used in a titratable or nontitratable manner.

The titratable appliances are two-piece appliance and they advance the mandible in increments whereas the nontitratable appliances are rigid single piece appliance which brings about maximum protrusion when inserted.\[[@ref3]\] Theoretically, mandibular advancement by titration decreases the stress produced on the TMJ and surrounding structures.\[[@ref3]\] The incremental mandibular advancement has been shown to produce greater degree of advancement as compared to single step advancement of mandible.\[[@ref4]\]

Few randomized controlled trials and observational studies compared titratable and fixed appliances in patients with mild to moderate sleep apnea. Systematic reviews and meta-analysis in the past identified the utility of oral appliances in sleep apnea\[[@ref5][@ref6]\] though these reviews addressed the effect of titration there were few studies that were not included for the analysis. Hence, this systematic review was compiled to identify the advantages of titratable over nontitratable mandibular advancement appliances used in patients with mild to moderate sleep apnea with snoring.

MATERIALS AND METHODOLOGY {#sec1-2}
=========================

Information sources and search strategy {#sec2-1}
---------------------------------------

The protocol for this review was registered with the international prospective register of systematic reviews (PROSPERO) with the registration number CRD42016045721. The review protocol can be accessed at <http://www.crd.york.ac.uk/PROSPERO/register_new_review.asp>. A through literature search was conducted and was completed on August 14, 2016. The primary database used was medline (via PubMed), Cochrane Central Register of Clinical Trials and Database of Abstracts of Reviews of Effects. The search strategy used was (mandibular advancement device) and mandibular advancement appliance. This search was further supplemented by hand searching of relevant references from review articles and other eligible studies. No limits were applied to the year of study, but studies published only in English language were included.

Eligibility criteria {#sec2-2}
--------------------

Only those studies with the following requirements were included in the present study:

Type of participants: Patients diagnosed with mild to moderate sleep apnea using apnea-hypopnea index (AHI) or polysomnographyTypes of intervention: Titratable or adjustable mandibular advancement appliance therapyComparison: Nontitratable or nonadjustable mandibular advancement appliance therapyOutcome: The outcomes reported were posttreatment AHI, polysomnography, Epworth Sleep Scale questionnaire.

Study procedure {#sec2-3}
---------------

Both the authors independently screened the above-mentioned databases for studies and independently reviewed abstracts for suitability. Full-texts articles were obtained for those found to be eligible and for those that were inconclusive on the abstract screening. A pretested data extraction form was created and both the authors independently extracted the following data from each eligible study: trial site, year, trial methods, participants, interventions, and outcomes. Disagreement between the authors was resolved through discussion. A significant heterogeneity was seen between the eligible studies and so meta-analysis was not attempted. The present systematic review was conducted and presented in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.\[[@ref7]\] Cochrane risk of bias tool was used for assessing the risk of bias of randomized controlled trials and Newcastle-Ottawa scale for nonrandomized controlled trials and observational studies.\[[@ref8][@ref9]\]

RESULTS {#sec1-3}
=======

Search results {#sec2-4}
--------------

A total of 166 articles were identified using the search strategy. Full-text and reference screening of the obtained article led to three more studies that could be included. After through screening of all the obtained 169 papers, 5 studies were eligible for final inclusion which fit into the set inclusion criteria. The PRISMA flow diagram is presented in [Figure 1](#F1){ref-type="fig"}. [Table 1](#T1){ref-type="table"} lists the key studies included.\[[@ref10][@ref11][@ref12][@ref13][@ref14]\]

![Preferred reporting items for systematic reviews and meta-analyses flow diagram](JIPS-17-319-g001){#F1}

###### 

Key characteristics of the included studies
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Key features of the included studies {#sec2-5}
------------------------------------

Of the five included studies, three were observational (two were prospective cohort and one was a retrospective review) and two were short-term cross-over randomized trial. All these studies were conducted in adults. The outcome attributes were polysomnographic readings and AHI. The study design and principles between the studies exhibited clinical heterogeneity. Hence, the principles of meta-analysis could not be applied. Risk of bias of randomized studies according to Cochran\'s tool \[[Table 2](#T2){ref-type="table"}\] showed high risk in terms of randomization sequence generation and allocation concealment. There was no mention regarding the blinding of participants, or the personal and the bias of blinding remains unclear. For studies that were nonrandomized, minimal risk of bias was observed as measured by Newcastle-Ottawa scale \[[Table 3](#T3){ref-type="table"}\].

###### 

Risk of bias of randomized controlled trials using Cochrane risk of bias tool
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###### 

Risk of bias as per Newcastle-Ottawa scale for observational and nonrandomized studies

![](JIPS-17-319-g004)

Considering the results obtained from the studies that were included and compiled as a systematic review, there is a tendency for the titratable oral appliances to produce a better reduction in polysomnographic and AHI measurements although a statistically significant improvement cannot be calculated due to inability to perform the meta-analysis. However, results from individual studies provide evidence that titratable appliances could produce favorable results as regards to reduction in AHI and polysomnography. None of the studies made an attempt to identify the adverse effects of using these appliances on the TMJ and the surrounding musculature and structures. Furthermore, these studies were limited to short duration, and the long-term effects of these appliances on sleep apnea could not be studied in detail.

DISCUSSION {#sec1-4}
==========

This systematic review identifies the advantages of using a titratable mandibular advancement appliance compared to nontitratable appliances in cases of mild to moderate sleep apnea. Eligible studies were identified from electronic databases, and four studies were included for the final review. Unfortunately, only one out of these was a short-term crossover randomized controlled trials. The others were either retrospective or prospective studies. The most important limitation in the included studies was that there was significant clinical heterogeneity between the studies which makes it difficult to compile evidences and conclude.

Appliance therapy for mild to moderate OSA has been into practice for many years in cases of mild to moderate sleep apnea. These appliances are either prefabricated or custom made.\[[@ref2]\] Considering the amount of diverse appliances available in the market it becomes impossible for the clinician to decide on the appliance that could produce predictable results with less adverse effects on the perioral structures.

Mandibular advancement devices and tongue retaining devices have been prescribed more commonly and they are usually custom made. However, mandibular advancement devices have been more commonly used by clinicians.\[[@ref5][@ref6]\] Mandibular advancement devices open the airway by moving the mandible forward. As the jaw is moved forward, the collapsible part of the airway is held open by the forward movement of the tongue and other airway muscles. These appliances also improve the strength and rigidity of the airway by increasing the muscle activity of the tongue and other muscles of the airway. The forward movement produced by these appliances could be an incremental movement produced by titratable appliances or a complete movement produced by nontitratable appliances.\[[@ref15][@ref16]\] The decision on using a titratable or nontitratable appliance can only be based on the evidence available from literature. Due to the lack of such evidence this systematic review was attempted.

The new era of appliance therapy for sleep apnea with incremental protrusion of the mandible has been reported to be efficacious in producing better reduction in AHI.\[[@ref5][@ref6]\] However, the number of randomized controlled clinical trials on which this could be based are very few. The clinical practice guideline (American Academy of Sleep Medicine 2015) for treatment of sleep apnea with appliances suggests the use of custom made titratable appliances over nonadjustable prefabricated appliances.\[[@ref17]\] Unfortunately, there were only four studies that were identified and only one was a short-term randomized cross-over trial. The success of treatment of OSA can be defined from the reduction in AHI and also comparing baseline polysomnography with posttreatment polysomnogram.\[[@ref17][@ref18][@ref19]\] A systematic compilation of the available studies was attempted and results from individual studies supported the use of titratable oral appliances for better reduction of AHI and polysomnographic readings when used in patients with mild to moderate sleep apnea. However, the adverse effects on the long-term use of these appliances lack evidence. Because of the clinical heterogeneity of the included studies, a meta-analysis could not be performed.

To conclude, there is a definite lack of randomized controlled trials that could identify the effect of titration of oral appliances for sleep apnea. This paper will serve as a basis on which future trials could be based. If the clinical heterogeneity between the studies could be minimized the principles of network meta-analysis could be applied to compile the evidences and could identify a possible conclusion.
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